Klotho Neurosciences, Inc.
KLTO
$1.54
$0.042.67%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -2.23M | -2.07M | -2.96M | -451.60K | -672.00K |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.15M | 814.20K | 1.91M | 40.00K | 287.30K |
| Change in Net Operating Assets | -464.90K | 308.90K | -25.40K | -495.70K | 362.80K |
| Cash from Operations | -1.55M | -944.20K | -1.07M | -907.40K | -22.00K |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | 0.00 | 0.00 | 0.00 | -123.50K |
| Cash from Investing | -- | 0.00 | 0.00 | 0.00 | -123.50K |
| Total Debt Issued | 2.12M | 1.20M | 150.00K | 950.00K | -- |
| Total Debt Repaid | -- | -120.00K | -- | -- | -- |
| Issuance of Common Stock | -- | 0.00 | 0.00 | 125.00K | 175.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -125.00K | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -65.20K | -120.00K | 128.50K | 770.40K | -- |
| Cash from Financing | 2.06M | 957.00K | 278.50K | 1.72M | 175.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 502.10K | 12.80K | -794.40K | 813.00K | 29.50K |